KIMBERLY CARLISLE: Open Payments
NPI 1518620905 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,351 in 145 payments from 31 companies in 2025. Trend: 2023 $2,738 · 2024 $2,988 · 2025 $3,351
Food & beverage: $3,267Education: $84
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $413 |
| PFIZER INC. | 20 | $347 |
| ABBVIE INC. | 25 | $310 |
| ARGENX US, INC. | 7 | $262 |
| Novartis Pharmaceuticals Corporation | 12 | $256 |
| Janssen Biotech, Inc. | 7 | $214 |
| Neurocrine BioSciences, Inc. | 6 | $213 |
| SK Life Science, Inc. | 4 | $133 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $121 |
| Biogen, Inc. | 4 | $117 |
Products named: NURTEC ODT, KESIMPTA, INGREZZA, UBRELVY, Rystiggo, VYVGART, FYCOMPA, Nayzilam.
Industry payments across GA — which companies pay providers there.
